Skip to main content

Table 1 Unique combinations of proteins that can be used as promising immunotherapeutic targets

From: Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach

Knock-in

Knock-out

Th1 response up-regulation

NO increase

Th2 response down-regulation

Anti-Leishmania Immunityb

Figure

IL12a

–

Yes

No

Yes

No

6c

IFN_GAMMA_Ta

–

Yes

No

Yes

No

6d

MKP_T

–

No

No

Yes

No

6e

TLR3

–

No

Yes

No

No

6f

–

SHP2_T

Yes

No

Yes

No

6g

–

SHC_T

No

No

No

No

6h

–

TLR2

Yes

Yes

Yes

Yes

6i

TLR3c

SHP2_Tc

Yes

Yes

Yes

Yes

6j

TLR3, MKP_Td

SHC_Td

Yes

Yes

Yes

Yes

6k

  1. arepresents previously known and commonly used immunotherapeutic targets; brepresents anti-Leishmania immunity that implies to a state when Th1 and NO response is up-regulated and the Th2 response is down-regulated; crepresents the proposed Combination 1; drepresents the proposed combination 2 treatment strategy